ClinicalTrials.gg
CompletedNCT01476397Updated Nov 4, 2014

Probiotic Formula and Infant Growth

An interventional study of Control infant formula and Test infant formula in Healthy, sponsored by Société des Produits Nestlé (SPN). Completed at 8 sites in United States. Open to participants aged 11 Days to 17 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-11-04.

Sponsored by Société des Produits Nestlé (SPN) (part of Nestlé S.A.) · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Ages
11 Days to 17 Days
Sex
All
01

Study summary

This is a growth study of full-term, formula-fed infants randomized to receive a partially hydrolyzed whey protein formula with and without probiotics for the first four months of life. It is hypothesized that there will be no difference in growth between the two groups.

02

Conditions studied

  • Healthy

Keywords

  • full-term
  • formula-fed infants
03

In context

Lead sponsor

Société des Produits Nestlé (SPN) is the lead sponsor of 324 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Days to 17 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy newborn infant
  • Full-term
  • Birth weight > 2500 and \< 4500 g
  • 14±3 days of age on enrollment
  • Exclusively formula-fed, singleton birth
  • Having obtained his/her legal representative's informed consent

Exclusion criteria

Exclusion Criteria:

  • Known or suspected cow-milk allergy
  • Congenital illness or malformation that may affect infant feeding and/or growth
  • Significant prenatal and/or postnatal disease
  • Any readmission to hospital prior to enrollment
  • Receiving prescription medication or frequent use of over the counter medications except vitamin and mineral supplements
  • Has received intravenous antibiotic therapy or oral probiotic in the last 7 days
  • Currently participating in another clinical study
  • Cannot be expected to comply with treatment
05

Study design

Phase
Not applicable

Study arms

  • Active comparator
    control infant formula

    partially hydrolyzed whey infant formula

    Other: Control infant formula

  • Experimental
    test infant formula

    partially hydrolyzed whey infant formula with probiotic

    Other: Test infant formula

Interventions

  • OtherControl infant formula

    partially hydrolyzed whey infant formula consumed ad libitum throughout study

  • OtherTest infant formula

    partially hydrolyzed whey formula with probiotic

06

What researchers measure

Primary outcomes

  1. growth

    weight gain assessed monthly

    Time frame: 4 months

Secondary outcomes

  1. other growth

    Length, head circumference will be measured at monthly visits

    Time frame: 4 months

  2. adverse events

    all adverse events will be documented throughout the study

    Time frame: 4 months

  3. stool characteristics

    stool frequency, color, consistency

    Time frame: throughout study

  4. spit-up

    frequency of spit-up as reported by caregivers

    Time frame: throughout study

  5. vomit

    frequency of vomitting as reported by caregivers

    Time frame: throughout study

07

Study locations

8 sites
  • North Scottsdale Pediatric Associates
    Scottsdale, Arizona 85258, United States
  • Pediatrics & Adolescent Medicine
    Marietta, Georgia 30189, United States
  • Kentucky Pediatric Adult Research
    Bardstown, Kentucky 40004, United States
  • PMG Research of Winston-Salem
    Winston-Salem, North Carolina 27103, United States
  • Medical University of South Carolina
    Charleston, South Carolina 29425, United States
  • PMG Research of Bristol
    Bristol, Tennessee 37620, United States
  • Pediatric Healthcare of Northwest Houston
    Tomball, Texas 77375, United States
  • Advanced Pediatrics
    Vienna, Virginia 22180, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 4, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01476397
Responsible party
Sponsor
First posted
Nov 22, 2011
Start date
Dec 2011
Primary completion
Jun 2013
Completion
Oct 2013
Last update
Nov 4, 2014

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion